EXHIBIT 10.6 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. DEVELOPMENT, SUPPLY AND LICENSE AGREEMENT This DEVELOPMENT SUPPLY AND LICENSE AGREEMENT ("Agreement") is made as...Supply and License Agreement • April 27th, 2004 • Oasis Semiconductor Inc • Semiconductors & related devices • Delaware
EXHIBIT 10 C.I. = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SUPPLY AND...Supply and License Agreement • August 7th, 2007 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • June 10th, 2005 • Hemosense Inc • Surgical & medical instruments & apparatus • Massachusetts
This Supply and License Agreement (“Agreement”) is made and entered into this 5th day of March, 1999, by and between Dade Behring Inc., (“Dade Behring”) a Delaware corporation with a principal place of business at 1717 Deerfield Road, Deerfield, Illinois 60015 and HemoSense, Inc., a Delaware corporation (“HemoSense”) having a principal place of business at 2157 O’Toole Avenue, Suite H, San Jose, California.
SUPPLY and LICENSE AGREEMENTSupply and License Agreement • November 5th, 2012 • Singulex Inc • Services-medical laboratories • California
This Supply and License Agreement (the “AGREEMENT”) is by and between MOLECULAR PROBES, INC. (“MPI”), an Oregon corporation, with a principal business address at 29851 Willow Creek Road, Eugene, Oregon 97402, INVITROGEN IP HOLDINGS, INC., a Delaware corporation with offices at 1600 Faraday Avenue, Carlsbad, California 92008 (“IIPH”), and SINGULEX, INC. (“SINGULEX”), a Delaware corporation, with a principal business address at 4041 Forest Park Avenue, St. Louis, Missouri 63108, and is effective as of June 12, 2006 (the “EFFECTIVE DATE”).
SUPPLY AND LICENSE AGREEMENT BETWEENSupply and License Agreement • July 20th, 2021
This Supply and License Agreement (the “Agreement”) is entered into and made effective as of July 30, 2020 (the “Effective Date”), by and between Serum Institute of India Private Limited., an Indian company having its principal place of business at 212/2, Off Soli Poonawalla Road, Hadapsar, Pune 411028 (“SIIPL”, which expression shall, unless repugnant to the context thereof, mean and include its successors and permitted assigns), and Novavax, Inc., a Delaware, USA corporation having its principal place of business at 21 Firstfield Road, Gaithersburg, MD 20878 USA (“Novavax”, which expression shall, unless repugnant to the context thereof, mean and include its Affiliates). Novavax and SIIPL may each be referred to herein individually as a “Party” and collectively as the “Parties.”
SUPPLY AND LICENSE AGREEMENT BETWEEN GEMA Biotech S.A. San Vladimiro 3056, San Isidro, Province of Buenos Aires, Argentina AND Serendex ApS CVR 3053 2228 Slotsmarken 12,1 2970 Horsholm DenmarkSupply and License Agreement • March 13th, 2017 • Mast Therapeutics, Inc. • Pharmaceutical preparations
[***] Indicates that information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
EX-10.1 2 d413801dex101.htm MANUFACTURING, SUPPLY AND LICENSE AGREEMENT Confidential Treatment Requested by BioDelivery Sciences International, Inc. IRS Employer Identification No. 35-208985 Confidential treatment requested with respect to certain...Supply and License Agreement • May 5th, 2020
This Manufacturing, Supply, and License Agreement (the “Agreement”) is made as of April 26, 2012 (the “Effective Date”) by and between Arius Pharmaceuticals, Inc. (a wholly-owned subsidiary of BioDelivery Sciences International, Inc.), a Delaware corporation with an office at 801 Corporate Center Drive, Suite 210, Raleigh, North Carolina 27607 USA (“BDSI”), and LTS LOHMANN Therapie-Systeme AG, a limited liability company organized and existing under the laws of Germany, having its executive offices and principal place of business at Lohmannstrasse 2, 56626 Andernach, Germany (“LTS”). BDSI and LTS are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”
EX-10.21 16 g05278a3exv10w21.htm EX-10.21 SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • May 5th, 2020 • New York
NOTE: Portions of this exhibit indicated by [*] are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit have been filed with the Securities and Exchange Commission as part of the Company’s confidential treatment request. SUPPLY AND LICENSE AGREEMENT This Supply and License Agreement (“Agreement”) is made and entered into as of this 7th day of June, 2007 (the “Effective Date”), by and between BioLife Solutions, Inc. (“BioLife”), and Bioheart, Inc. (“Customer”). RECITALS The parties desire to enter into an agreement pursuant to which (i) BioLife shall supply Customer with all its requirements for BioLife Products (as defined below) to Customer, (ii) Customer shall purchase all its requirements for BioLife Products from BioLife, and (iii) BioLife shall place certain of its proprietary technology and know how into escrow, and agree to grant Customer a license to use such technology and know how in the event a Rel
AMENDMENT NO. 5 TO THE SUPPLY AND LICENSE AGREEMENT BY AND BETWEEN HESKA CORPORATION ANDSupply and License Agreement • May 10th, 2016 • Heska Corp • Biological products, (no disgnostic substances)
This AMENDMENT NO. 5, dated as of this 30th day of October, 2015 (“Amendment No. 5”), to the Supply and License Agreement, dated as of August 1, 2003 (as amended from time to time and hereinafter collectively referred to as the “Agreement”), is made by and between INTERVET INC., d/b/a MERCK ANIMAL HEALTH (“MAH”), and HESKA CORPORATION (“Heska”).
EX-10.7 3 dex107.htm COMMERCIAL SUPPLY AND LICENSE AGREEMENT WITH LOHMANN THERAPIE-SYSTEME AG [***]CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION...Supply and License Agreement • May 5th, 2020
This COMMERCIAL SUPPLY AND LICENSE AGREEMENT (this “Agreement”), is entered into as of day of January, 2007 (“Effective Date”) by and between
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • February 8th, 2024 • Solidion Technology Inc. • Miscellaneous electrical machinery, equipment & supplies • Delaware
This Supply and License Agreement (this “Agreement”) is made by and between Global Graphene Group, Inc., a Delaware corporation (“G3”), Angstron Materials, Inc., an Ohio corporation (“AMI”), and Honeycomb Battery Company, an Ohio corporation (“Customer”), and is effective as of February 2, 2024 (the “Effective Date”). G3, AMI and Customer are sometimes collectively referred to hereafter as the “Parties” and each individually as a “Party”.
EX-10.02 3 dex1002.htm SUPPLY AND LICENSE AGREEMENT SUPPLY AND LICENSE AGREEMENT (INTERNATIONAL TERRITORIES)Supply and License Agreement • May 5th, 2020 • Utah
This Agreement is made effective as of April 9, 2007 by and between Colloral LLC, a Delaware limited liability company (“Colloral”), and Futurebiotics, LLC, a New York limited liability company (“Futurebiotics, LLC”).
Amendment No. 1 to the Supply and License AgreementSupply and License Agreement • May 13th, 2024 • Golden Arrow Merger Corp. • Industrial organic chemicals
This Amendment No. 1 to Supply and License Agreement (this “Amendment”) is made as of 8/19/2022 between Bolt Threads, Inc., a Delaware corporation (“Bolt”), and Vegamour, Inc., a Delaware corporation (“Vegamour”) (together, the “Parties”).
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 30th, 2007 • Heska Corp • Biological products, (no disgnostic substances) • Delaware
This Agreement is entered into on 1 August 2003 (“Effective Date”), by and between Heska Corporation, a Delaware corporation, having a principal place of business at 1613 Prospect Parkway, Fort Collins, Colorado 80525 (“Heska”) and Schering-Plough Animal Health Corporation, a Delaware corporation, having a place of business at 1095 Morris Avenue, Union, New Jersey 07083-1982 (“Schering”).
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • February 5th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Supply and License Agreement (hereinafter referred to as “Agreement”), effective as of the 27th day of June, 2006 (the “Effective Date”), is made by and between SPI Pharma, Inc., a Delaware corporation with its principal offices at 321 Cherry Lane, New Castle, Delaware 19720 (hereinafter referred to as “Supplier”) and TransOral Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 1003 W. Cutting Blvd., Suite 110, Pt. Richmond, California 94804 (hereinafter referred to as “Purchaser”). Purchaser and Supplier are sometimes referred to herein individually as a “Party” or collectively as the “Parties”.
AMENDMENT #2 TO SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • November 16th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amendment #2 (hereinafter referred to as this “Amendment”), dated as of the 30th day of July, 2009 (the “Amendment Date”), is made by and between SPI Pharma, Inc., a Delaware corporation with its principal offices at Rockwood Office Park, 503 Carr Road, Wilmington, Delaware 19809 (hereinafter referred to as “Supplier”), and Pivot Acquisition, Inc., a Delaware corporation formerly known as Transcept Pharmaceuticals, Inc. (hereinafter referred to as “Purchaser”) and a wholly-owned subsidiary of Transcept Pharmaceuticals, Inc. (a publicly-traded Delaware corporation hereinafter referred to as “Transcept”) with its principal offices at 1003 W. Cutting Blvd., Suite 110, Pt. Richmond, California 94804. Purchaser and Supplier are sometimes referred to herein individually as a “Party” or collectively as the “Parties”.
AMENDMENT NO 3 TO SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • November 14th, 2013 • Heska Corp • Biological products, (no disgnostic substances)
This Amendment No. 3 is entered into as of July 30th, 2013 by and between Heska Corporation, a Delaware corporation, having a principal place of business at 3760 Rocky Mountain Avenue, Loveland, CO 80538 ("Heska") and Intervet Inc., d/b/a Merck Animal Health a Delaware corporation, having a place of business at 556 Morris Avenue, Summit, New Jersey 07901-1330 ("Merck").
CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. Amendment to SUPPLY AND LICENSE AGREEMENT DATED 30 JULY 2020 (“Agreement”)...Supply and License Agreement • November 10th, 2020 • Novavax Inc • Biological products, (no disgnostic substances)
This Amendment (“Amendment”) to the SUPPLY AND LICENSE AGREEMENT dated July 30, 2020 (“Agreement”), is entered into between Novavax, Inc., a Delaware, USA corporation having its principal place of business at 21 Firstfield Road, Gaithersburg, MD 20878 USA (“Novavax”, which expression shall, unless repugnant to the context thereof, mean and include its Affiliates) and Serum Institute of India Private Limited, a company incorporated under the Companies Act, 1956 with registration number U80903PN1984PTC03294, and having its registered address as 212/2, Off Soli Poonawalla Road, Hadapsar, Pune 411028 (“SIIPL”, which expression shall, unless repugnant to the context thereof, mean and include its successors and permitted assigns), and is entered into and made effective as of September 11, 2020 (“Effective Date of Amendment”). All capitalized terms or otherwise undefined terms herein this Amendment shall have the same meaning and interpretation as in the Agreement
ContractSupply and License Agreement • March 31st, 2014 • Heska Corp • Biological products, (no disgnostic substances)
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • November 3rd, 2011 • Efactor Holdings Inc • Nevada
This SOFTWARE SUPPLY AND LIECNSE AGREEMENT (“Agreement”) is effective as of the 9th day of September, 2011 (“the Effective Date”) between Triton Distribution Systems, Inc., having offices at 105 Barbaree Way, Tiburon, CA 94920 (“Triton”); and EFactor Holdings, Inc. ("EHI"), having offices at 105 Barbaree Way, Tiburon, CA 94920.
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • February 6th, 2008 • Cti Industries Corp • Fabricated rubber products, nec • Wisconsin
As and when requested by Johnson in writing, Supplier shall promptly provide Johnson with all information necessary for Johnson to comply with all legal and regulatory requirements relating to the Products or any products in which the Products are to be incorporated, including, without limitation, the registration, packaging, labeling and provision of safety information (e.g., material safety data sheet) in all countries where products incorporating the Products are sold from time to time. Johnson may disclose such information as required by applicable law.
Exhibit 10.67.2 AMENDED AND RESTATED PROPRIETARY REAGENT SUPPLY AND LICENSE AGREEMENT THIS AMENDED AND RESTATED PROPRIETARY REAGENT SUPPLY AND LICENSE AGREEMENT (the "Agreement"), is made and entered into as of June 6, 2002 by and between DTE Smith...Supply and License Agreement • December 24th, 2002 • Headwaters Inc • Miscellaneous products of petroleum & coal • New York
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 31st, 2005 • Heska Corp • Biological products, (no disgnostic substances) • Delaware
This Agreement is entered into on 1 August 2003 ("Effective Date"), by and between Heska Corporation, a Delaware corporation, having a principal place of business at 1613 Prospect Parkway, Fort Collins, Colorado 80525 ("Heska") and Schering-Plough Animal Health Corporation, a Delaware corporation, having a place of business at 1095 Morris Avenue, Union, New Jersey 07083-1982 ("Schering").
AMENDMENT NO. 1 TO SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 16th, 2009 • Heska Corp • Biological products, (no disgnostic substances)
This Amendment No. 1 modifies the Supply and License Agreement between Heska Corporation and Schering-Plough Animal Health Corporation, dated August 1, 2003 (“Original Agreement”).
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • August 12th, 2003 • Allin Corp • Services-computer integrated systems design • Colorado
This SUPPLY AND LICENSE AGREEMENT together with its Schedules (the “Agreement”) is entered into this 30th day of June 2003 (the “Effective Date”) by ALLIN INTERACTIVE CORPORATION, a Delaware corporation having its principal office at 381 Mansfield Avenue, Suite 400, Pittsburgh, PA 15220 (“Allin”), and ON COMMAND VIDEO CORPORATION, a Delaware corporation with offices at 4610 South Ulster, Suite 600, Denver, Colorado 80237 (“OCV”). For the purpose of this Agreement, Allin and OCV are each a “Party” and are collectively, the “Parties.”
Amendment No. 1 to the Supply and License AgreementSupply and License Agreement • June 5th, 2024 • Golden Arrow Merger Corp. • Industrial organic chemicals
This Amendment No. 1 to Supply and License Agreement (this “Amendment”) is made as of 8/19/2022 between Bolt Threads, Inc., a Delaware corporation (“Bolt”), and Vegamour, Inc., a Delaware corporation (“Vegamour”) (together, the “Parties”).
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [****], HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(b)(10)(iv). SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. OEM SUPPLY AND...Supply and License Agreement • March 3rd, 2021 • Olink Holding AB (Publ) • Laboratory analytical instruments • Minnesota
This Manufacturing Supply Agreement, dated as of August 10, 2016 (the “Agreement”), is entered into by and between Bio-Techne Corp., a Minnesota corporation having its principal place of business at 614 McKinley Place NE (“Bio-Techne”), and Olink Proteomics AB, a Swedish company, registration no. 559046-8632, having an address at Dag Hammarskjölds väg 52B, SE-752 37 Uppsala, Sweden (“Buyer”, and together with Bio-Techne, the “Parties”, and each, a “Party”).
Supply and License AgreementSupply and License Agreement • March 31st, 2021 • Triangle Canna Corp. • Agricultural production-crops • California
This Supply Agreement (“Agreement”) is entered into as of March 15, 2021 (“Effective Date”), by and between Bar X Farms LLC, a California limited liability company (“Purchaser”), and Humboldt Standard LLC, a California limited liability company (“Supplier”). Supplier and Purchaser are each referred to herein as a “Party” and, collectively, the “Parties.”
EX-10.4 6 d938337dex104.htm SECOND AMENDED AND RESTATED SUPPLY AND LICENSE AGREEMENT FOIA CONFIDENTIAL TREATMENT REQUEST BY HEDGEPATH PHARMACEUTICALS, INC. IRS EMPLOYER IDENTIFICATION NUMBER 30-0793665 ***CONFIDENTIAL TREATMENT REQUESTED*** Note:...Supply and License Agreement • May 5th, 2020 • Delaware
AMENDMENT NO. 6 TO THE SUPPLY AND LICENSE AGREEMENT BY AND BETWEEN HESKA CORPORATION AND INTERVET INC., d/b/a MERCK ANIMAL HEALTHSupply and License Agreement • March 9th, 2018 • Heska Corp • Biological products, (no disgnostic substances)
This AMENDMENT NO. 6, dated as of this 27th day of November, 2017 ("Amendment No. 6"), to the Supply and License Agreement, dated as of August 1, 2003, as amended by that certain Amendment No.1, dated as of August 31, 2005; that certain Amendment No. 2, dated as of December 7, 2011; that certain Amendment No. 3, dated as of July 30, 2013; that certain Amendment No. 4 dated as of December 9, 2013; that certain Amendment No. 5 dated as of October 30, 2015; and that certain Letter Agreement dated as of August 14, 2015 (collectively, the "Agreement"), is made by and between INTERVET INC., d/b/a MERCK ANIMAL HEALTH ("MAH"), and HESKA CORPORATION ("Heska").
AMENDMENT #1 TO SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • February 5th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment #1 (this “Amendment #1”), effective as of March 14, 2008 (the “Effective Date”), is made by and between SPI Pharma, Inc., a Delaware corporation with its principal offices at 321 Cherry Lane, New Castle, Delaware 19720 (hereinafter referred to as “Supplier”) and Transcept Pharmaceuticals, Inc. (formerly, TransOral Pharmaceuticals), a Delaware corporation with its principal offices at 1003 W. Cutting Blvd., Suite 110, Pt. Richmond, California 94804. SPI and the Transcept may be referred to herein by name or as a “Party,” or collectively as the “Parties.”
Supply and License AgreementSupply and License Agreement • May 21st, 2020 • Pure Bioscience, Inc. • Miscellaneous chemical products • California
This SUPPLY AND LICENSE AGREEMENT (this “Agreement”) is entered into as of May 1, 2020 (“Effective Date”) by and between Pure Bioscience, Inc., a Delaware corporation with its principal place of business at 9669 Hermosa Avenue, Rancho Cucamonga, CA 91730, hereinafter (“Supplier” or “PURE” or “Pure”), and Packers Sanitation Services, Inc., an Ohio corporation with its principal place of business at 3681 Prism Lane, Kieler, WI 53812, hereinafter (“Licensee”), each referred to as “Party” and collectively as “Parties.”
Confidential Treatment Requested by ITUS Corporation, IRS Employer Identification No. 30-0793665 ***CONFIDENTIAL TREATMENT REQUESTED*** NOTE: CONFIDENTIAL TREATMENT REQUESTED WITH RESPECT TO CERTAIN PORTIONS HEREOF DENOTED WITH “[***]” AMENDMENT NO. 2...Supply and License Agreement • January 11th, 2018 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED SUPPLY AND LICENSE AGREEMENT AND AMENDMENT NO. 1 TO SUBLICENSE AGREEENT (the “Amendment”), effective as of January 10, 2018 (the “Effective Date”), is made by and among:
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 31st, 2010 • Converted Organics Inc. • Agricultural chemicals • Massachusetts
This supply and license agreement (“Agreement”), effective as of March 23, 2010 (“Effective Date”), is by and among Converted Organics Inc., a Delaware corporation with principal offices at 137 Lewis Wharf, Boston, MA 02110 (“COIN”), Heartland Technology Partners, LLC, a Colorado limited liability company with principal offices at 9870 Big Bend Road, Kirkwood, MO 63122 (“HTP”), and Emend, LLC, a New York limited liability company with principal offices at 4 Partridge Lane, Goshen, NY 10924 (“Emend”) (HTP and Emend being collectively, “Licensors”), each referred to as a “Party” and collectively the “Parties”.
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 17th, 2008 • Orthovita Inc • Surgical & medical instruments & apparatus • California
This Supply and License Agreement (this “Agreement”) is entered into as of November 5, 2007 (“Effective Date”) by and between (i) Allergan, Inc., a Delaware corporation, and Allergan Sales, LLC, a Delaware limited liability company, each having a principal place of business at 2525 Dupont Drive, Irvine, California 92612 (collectively “Allergan”) and (ii) Orthovita, Inc., a Pennsylvania corporation, having a principal place of business at 77 Great Valley Parkway, Malvern, Pennsylvania 19355 (“Orthovita”). Allergan and Orthovita shall hereinafter be individually referred to as a “Party” and collectively as the “Parties”.
